Sarmad Nory Gany¹, Naseer N al Harchan², Muhsin Abdulhussein Al-Dhalimi³, Najah R Hadi*¹  AbstractPsoriatic patients with plaque psoriasis particularly those with high body mass index have increasing risk of developing a diabetes mellitus type 2 (DM). Since both conditions are associated with dysregulation in DPP-IV, DPP-IV inhibitors have been suggested as therapeutic drugs for both […]